FAGRON (FAGR.BR) Stock Overview
Europe - EBR:FAGR - BE0003874915 - Common Stock
FAGR.BR Key Statistics, Chart & Performance
The current stock price of FAGR.BR is 20.75 EUR. In the past month the price increased by 5.91%. In the past year, price increased by 10.99%.
FAGR.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABG.DE | CENCORA INC | 21.5 | 55.60B | ||
| AMP.MI | AMPLIFON SPA | 26.92 | 3.54B | ||
| UPR.I | UNIPHAR PLC | 18.18 | 1.04B | ||
| ILM1.DE | MEDIOS AG | 17.24 | 325.51M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 113.41 | 183.88M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 71.69M |
Related stock screener links
About FAGR.BR
Company Profile
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Company Info
FAGRON
Venecoweg 20A
Nazareth OOST-VLAANDEREN BE
Employees: 3989
Phone: 3280012880
FAGRON / FAGR.BR FAQ
Can you describe the business of FAGRON?
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
What is the current price of FAGR stock?
The current stock price of FAGR.BR is 20.75 EUR. The price decreased by -0.24% in the last trading session.
What is the dividend status of FAGRON?
FAGRON (FAGR.BR) has a dividend yield of 1.16%. The yearly dividend amount is currently 0.29.
How is the ChartMill rating for FAGRON?
FAGR.BR has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What sector and industry does FAGRON belong to?
FAGRON (FAGR.BR) operates in the Health Care sector and the Health Care Providers & Services industry.
What is FAGRON worth?
FAGRON (FAGR.BR) has a market capitalization of 1.53B EUR. This makes FAGR.BR a Small Cap stock.
FAGR.BR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to FAGR.BR. When comparing the yearly performance of all stocks, FAGR.BR is a bad performer in the overall market: 63.64% of all stocks are doing better.
FAGR.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to FAGR.BR. FAGR.BR scores excellent on profitability, but there are some minor concerns on its financial health.
FAGR.BR Financial Highlights
Over the last trailing twelve months FAGR.BR reported a non-GAAP Earnings per Share(EPS) of 1.18. The EPS increased by 10.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.33% | ||
| ROA | 7.66% | ||
| ROE | 17.1% | ||
| Debt/Equity | 0.78 |
FAGR.BR Forecast & Estimates
13 analysts have analysed FAGR.BR and the average price target is 25.31 EUR. This implies a price increase of 21.98% is expected in the next year compared to the current price of 20.75.
For the next year, analysts expect an EPS growth of 15.36% and a revenue growth 9.24% for FAGR.BR